Hemostasis & Tissue Sealing Agents Market Analysis | CMI - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Hemostasis & Tissue Sealing Agents Market Analysis | CMI

Description:

Read here the latest updates on the Hemostasis & Tissue Sealing Agents Market Analysis published by CMI team – PowerPoint PPT presentation

Number of Views:2

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Hemostasis & Tissue Sealing Agents Market Analysis | CMI


1
  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

2
HEMOSTASIS TISSUE SEALING AGENTS MARKET ANALYSIS
  • Hemostasis Tissue Sealing Agents Market, by
    Product Type (Topical Hemostats Adhesives
    Tissue Sealing Agents), by End User (Hospitals,
    Ambulatory Surgical Centers Home Care Settings)
    and by Region - Global Industry Insights and
    Forecast to 2025
  • The global hemostasis tissue sealing agents
    market was valued at US 3,236.2 million in 2017
    and is expected to witness a robust CAGR of 8.1
    over the forecast period (20172025).

3
Figure 1. Global Hemostasis Tissue Sealing
Agents Market Value (US Mn), by Region, 2017
4
Market Drivers
  • Rising number of surgical procedures coupled with
    increasing trauma cases to foster global
    Hemostasis Tissue Sealing Agents Market
  • Factors such as increasing number of surgical
    procedures as well as rising number of road
    accidents are expected to significantly
    contribute to growth of the hemostasis and tissue
    sealing agents market. For instance, according to
    Health and Social Care Information Centre
    (HSCIC), surgery is one of the most important
    treatments offered by NHS care in the U.K., and
    accounted for 4.7 million admissions across
    multiple sectors in 2013-14. The data also
    suggests that the number of surgical procedures
    has increased by 27 between 2004 and 2014.
    According to Centers of Disease Control and
    Prevention (CDC), around 200,000 deaths were
    encountered in 2014, due to trauma injuries in
    the U.S. Increasing incidence of road accidents
    has led to traumatic sport injuries is a major
    factor fueling demand for hemostats, thereby
    driving the market growth. According to the World
    Health Organization 2016, over 50 affected in
    road traffic accidents were admitted in the
    hospitals and underwent trauma surgeries.
    Hemostats are used in trauma surgeries and also
    in various conventional surgeries such as hernia
    repair surgery, orthopedic, open heart and
    cardiovascular surgeries, and neurosurgery that
    involve significant blood loss, due to larger
    size incisions made on the body of the patient.
    According to the annual report of American Joint
    Replacement Registry (AJRR), 2016, a total of
    427,181 procedures were reported for joint
    replacement surgeries. However, lack of favorable
    reimbursement policies for failure of hemostats
    in blood loss control as well as increasing cost
    of surgical procedures is expected to hinder the
    market growth.

5
  • North America to dominate global hemostasis
    tissue sealing agents owing to incorporation of
    newer technologies in new products and extensive
    research development for the same
  • In terms of region, North America is the dominant
    in the global hemostasis tissue sealing agents
    market. This is attributed to rapid development
    and launch of novel tissue sealing compounds and
    products by key players in the market in the
    region. For instance, in March 2018, BodeVet,
    Inc., a blood-related products company,
    introduced StablePlate RX Canine as the worlds
    first injectable freeze dried platelet derived
    product used for the treatment of acute
    uncontrolled hemorrhage in bleeding patients. In
    December 2012, Ethicon, Inc., a company offering
    hemostasis and sealing solutions, received U.S.
    FDA approval for EVARREST Fibrin Sealant patch
    that rapidly and reliably aids in stopping
    problematic bleeding during surgery.
  • On the other hand, Asia Pacific is expected to
    exhibit high growth over the forecast period,
    owing to rising number of surgical procedures as
    a result of increasing medical tourism in
    emerging economies such as China, Singapore, and
    India. For instance, according to an article
    published by OrthoStreams, a privately held
    orthopedic devices company, orthopedic surgeries
    in China and other emerging economies are 75
    cost effective as compared procedures performed
    in the U.S. Additionally, rising number of road
    accidents in Asia Pacific region leading to
    trauma admissions in emergency departments also
    contributes to the growth of the market in the
    region over the forecast period. According to the
    Ministry of Road Transport and Highways,
    Government of India, the total number of persons
    injured in road accidents in 2015 are 500,279.
    These are expected to aid in growth of the
    market.

6
  • Market players are launching innovative products
    to sustain their position in the global
    hemostasis tissue sealing agents market
  • Key players in the market are focused on
    expansion of their presence through launch of new
    product lines in emerging economies. For
    instance, in March 2018, Baxter International,
    Inc. completed acquisition of two hemostat
    products from Mallinckrodt Plc and announced to
    widen its customer base through launch of
    RECOTHORM and PREVELEAK hemostat sealant in
    Japan. Moreover, players are also focusing on
    offering innovative products, in order to enhance
    their market share. For instance, in January
    2018, Ethicon LLC, a part of Johnson Johnson
    Medical Devices Companies, introduced SURGICEL
    powdered absorbable hemostat that assists to
    combat disruptive bleeding on broad and oozing
    surfaces.

7
Key Players
  • Key players operating the global hemostasis
    tissue sealing agents market include Cryolife,
    Inc. Baxter International, Inc., Ethicon LLC,
    Integra Lifesciences Corporation, Becton,
    Dickinson Company, Cohera Medical, Inc.,
    Pfizer, Inc., Medtronic plc, B. Braun Melsungen
    AG, MIL Laboratories Pvt. Ltd, Advanced Medical
    Solutions Group Plc, and others.

8
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//www.coherentmarketinsights.com
    /market-insight/hemostasis-and-tissue-sealing-agen
    ts-market-1567

9
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

10
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
    U.S.
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

11
  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com